Loading
An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.
To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors. ClinicalTrials.gov record last updated 2024-09-19: recruiting. Enrollment is planned at 140 participants. Primary completion is estimated at 2026-05-17. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/